These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 19816806)

  • 21. New indicators and indexes for benchmarking university-industry-government innovation in medical and life science clusters: results from the European FP7 Regions of Knowledge HealthTIES project.
    Edmunds LD; Gluderer S; Ovseiko PV; Kamerling R; Ton J; Vis L; Jenni M; Tutton G; Lawton-Smith H; Nadabán MV; Rab M; Rees J; Anson J; Rushforth AD; Allen M; Buchan AM; Vendrell M; Casta A; Mehes G; Hogendoorn PCW; Hafen E; Hassan AB
    Health Res Policy Syst; 2019 Jan; 17(1):10. PubMed ID: 30691504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rules to be adopted for publishing a scientific paper.
    Picardi N
    Ann Ital Chir; 2016; 87():1-3. PubMed ID: 28474609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A survey of enabling technologies in synthetic biology.
    Kahl LJ; Endy D
    J Biol Eng; 2013 May; 7(1):13. PubMed ID: 23663447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthetic biology industry: data-driven design is creating new opportunities in biotechnology.
    Freemont PS
    Emerg Top Life Sci; 2019 Nov; 3(5):651-657. PubMed ID: 33523172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Let's (not) talk about synthetic biology: Framing an emerging technology in public and stakeholder dialogues.
    Bauer A; Bogner A
    Public Underst Sci; 2020 Jul; 29(5):492-507. PubMed ID: 32122265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Turning science into policy: challenges and experiences from the science-policy interface.
    Watson RT
    Philos Trans R Soc Lond B Biol Sci; 2005 Feb; 360(1454):471-7. PubMed ID: 15814358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Future trends in synthetic biology in Asia.
    Mao N; Aggarwal N; Poh CL; Cho BK; Kondo A; Liu C; Yew WS; Chang MW
    Adv Genet (Hoboken); 2021 Mar; 2(1):e10038. PubMed ID: 36618442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Marine biotechnologies and synthetic biology, new issues for a fair and equitable profit-sharing commercial use.
    Bloch JF; Tardieu-Guigues E
    Mar Genomics; 2014 Oct; 17():79-83. PubMed ID: 25116370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthetic biology: mapping the scientific landscape.
    Oldham P; Hall S; Burton G
    PLoS One; 2012; 7(4):e34368. PubMed ID: 22539946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthetic biology: regulating industry uses of new biotechnologies.
    Erickson B; Singh R; Winters P
    Science; 2011 Sep; 333(6047):1254-6. PubMed ID: 21885775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Impact of synthetic biology on patent law in view of of European jurisprudence].
    Bernardo Alvarez MA
    Rev Derecho Genoma Hum; 2014; (41):123-40. PubMed ID: 25845209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. To be or not IP? Exploring limits within patent law for the constitutionalization of intellectual property rights and the governance of synthetic biology in human health.
    Schneider I
    Rev Derecho Genoma Hum; 2012; (37):193-233. PubMed ID: 23520920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How can developing countries harness biotechnology to improve health?
    Daar AS; Berndtson K; Persad DL; Singer PA
    BMC Public Health; 2007 Dec; 7():346. PubMed ID: 18053180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current state and prospects of biotechnology in Central and Eastern European countries. Part II: new and preaccession EU countries(CRO, RO, B&H, SRB).
    Dettenhofer M; Ondrejovič M; Slavica A; Kurtanjek Ž; Tapaloaga D; Rodian Tapaloaga P; Kapur Pojskić L; Durmić-Pašić A; Begović J; Nedović V; Dundar M; Gartland KMA; Miertuš S
    Crit Rev Biotechnol; 2019 Feb; 39(1):137-155. PubMed ID: 30372630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modelling human embryogenesis: embryo-like structures spark ethical and policy debate.
    Pereira Daoud AM; Popovic M; Dondorp WJ; Trani Bustos M; Bredenoord AL; Chuva de Sousa Lopes SM; van den Brink SC; Roelen BAJ; de Wert GMWR; Heindryckx B
    Hum Reprod Update; 2020 Nov; 26(6):779-798. PubMed ID: 32712668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A conceptual framework for understanding the perspectives on the causes of the science-practice gap in ecology and conservation.
    Bertuol-Garcia D; Morsello C; N El-Hani C; Pardini R
    Biol Rev Camb Philos Soc; 2018 May; 93(2):1032-1055. PubMed ID: 29160024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defining the Synthetic Biology Supply Chain.
    Frazar SL; Hund GE; Bonheyo GT; Diggans J; Bartholomew RA; Gehrig L; Greaves M
    Health Secur; 2017; 15(4):392-400. PubMed ID: 28767286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trends in Synthetic Biology Applications, Tools, Industry, and Oversight and Their Security Implications.
    Carter SR; Warner CM
    Health Secur; 2018; 16(5):320-333. PubMed ID: 30339097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A systematic review protocol for crime trends facilitated by synthetic biology.
    Elgabry M; Nesbeth D; Johnson SD
    Syst Rev; 2020 Feb; 9(1):22. PubMed ID: 32014050
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.